Red Tortoise LLC’s Regeneron Pharmaceuticals REGN Stock Holding History

Red Tortoise LLC’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.95K	Hold	9	–	–	﹤0.01%	341
2025 Q4	$6.95K	Hold	9	–	–	﹤0.01%	336
2025 Q3	$5.06K	Hold	9	–	–	﹤0.01%	382
2025 Q2	$4.72K	Buy	9 +3	+50%	+$1.67K	﹤0.01%	371
2025 Q1	$3.81K	Sell	6 -2	-25%	-$1.38K	﹤0.01%	393
2024 Q4	$5.7K	Hold	8	–	–	﹤0.01%	338
2024 Q3	$8.41K	Hold	8	–	–	﹤0.01%	286
2024 Q2	$8.41K	Hold	8	–	–	﹤0.01%	272
2024 Q1	$7.7K	Hold	8	–	–	﹤0.01%	275
2023 Q4	$7.03K	Buy	8 +3	+60%	+$2.47K	﹤0.01%	245
2023 Q3	$4.12K	Hold	5	–	–	﹤0.01%	310
2023 Q2	$3.59K	Hold	5	–	–	﹤0.01%	346
2023 Q1	$4.11K	Hold	5	–	–	﹤0.01%	300
2022 Q4	$3.61K	Buy	+5	New	+$3.69K	﹤0.01%	369
2021 Q4	–	Sell	-2	Closed	-$1K	–	410
2021 Q3	$1K	Buy	+2	New	+$1.24K	﹤0.01%	518

Other funds holding REGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Red Tortoise LLC's REGN Position: Q1 2026 in Review

Red Tortoise LLC held its Regeneron Pharmaceuticals (REGN) position steady in Q1 2026 at 9 shares worth $6.95K. The position accounts for ﹤0.01% of the portfolio, ranked #341.

Red Tortoise LLC first reported a position in REGN in Q3 2021 and has held it in 15 quarters since. The position peaked at $8.41K in Q3 2024. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

Red Tortoise LLC held 9 shares of Regeneron Pharmaceuticals worth $6.95K as of Q1 2026.
Red Tortoise LLC left its Regeneron Pharmaceuticals share count unchanged in Q1 2026.
Regeneron Pharmaceuticals made up ﹤0.01% of Red Tortoise LLC's portfolio in Q1 2026, its #341 holding.
Red Tortoise LLC first reported a position in Regeneron Pharmaceuticals in Q3 2021 and has held it in 15 quarters since.
Red Tortoise LLC's Regeneron Pharmaceuticals position peaked at $8.41K in Q3 2024.
1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Red Tortoise LLC's 13F filing for Q1 2026, filed 21 Apr 2026.